YEASEN commitment to developing and producing enzyme products.
Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 17, 2021 | Series B | ¥250M | 2 | Legend Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Legend Capital | Yes | Series B |
Step Fund | — | Series B |